# EDGAR Filing Document

**Accession Number:** 0001100663
**File Stem:** 0001752724-25-204366
**Filing Date:** 2025-8
**Character Count:** 18345
**Document Hash:** e0abdd9dc18f67463c211df09e75912b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-25-204366.hdr.sgml**: 20250826

**ACCESSION NUMBER**: 0001752724-25-204366

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250826

**DATE AS OF CHANGE**: 20250826

**PERIOD START**: 20260331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** iSHARES TRUST
- **CENTRAL INDEX KEY:** 0001100663

**ORGANIZATION NAME:**
- **EIN:** 943351276
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-09729
- **FILM NUMBER:** 251254498

**BUSINESS ADDRESS:**
- **STREET 1:** 400 HOWARD STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94105
- **BUSINESS PHONE:** (415) 670-2000

**MAIL ADDRESS:**
- **STREET 1:** 400 HOWARD STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94105

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ISHARES TRUST
- **DATE OF NAME CHANGE:** 19991213

## Series and Classes Contracts Data

### iShares U.S. Pharmaceuticals ETF (Series ID: S000009417)

| Class ID   | Class Name                       | Ticker Symbol   |
|:---|:---|:---|
| C000025771 | iShares U.S. Pharmaceuticals ETF | IHE             |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** iShares Trust

- **b. Investment Company Act file number:** 811-09729

- **c. CIK number of Registrant:** 0001100663

- **d. LEI of Registrant:** 5493000860OXIC4B5K91

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 400 Howard Street

  - **City:** San Francisco

  - **State:** CA

  - **Foreign country:** US

  - **Zip / Postal Code:** 94105

  - **Telephone number:** 800-474-2737

**Item A.2. Information about the Series.**

- **a. Name of Series:** iShares U.S. Pharmaceuticals ETF

- **b. EDGAR series identifier (if any):** S000009417

- **c. LEI of Series:** 549300K3OFF3L3ODU217

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-03-31

- **b. Date as of which information is reported:** 2025-06-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $582672762.70

**Total Liabilities:** $32220164.76

**Net Assets:** $550452597.94

**Cash Not Reported:** $9018.35

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000025771 | -3.14%               | -4.71%               | 1.10%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $22829046.89             | $-44067466.54                              |
| Month 2  | $4168220.84              | $-34743252.93                              |
| Month 3  | $-46176.31               | $6106572.88                                |

### Schedule of Portfolio Investments

| Name                                                                       | Title                                             | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Collegium Pharmaceutical, Inc.                                             | COLLEGIUM PHARMACEUTICAL INC                      | CUSIP: 19459J104<br>LEI: 54930049FXZMTLW8D496 | Long             | EC               | CORP              | US        |     88908 | NS      | $2629009.56   | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Mind Medicine (MindMed) Inc                                                | MIND MEDICINE MINDMED INC                         | CUSIP: 60255C885<br>LEI: 549300QY8KN1O6RPFJ13 | Long             | EC               | CORP              | CA        |    188477 | NS      | $1223215.73   | 0.22%             |  |  |  | No            |                  1 | On Loan: No      |
| BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agency Shares      | BLACKROCK CASH FUNDS TREASURY                     | CUSIP: 066922477<br>LEI: N/A                  | Long             | STIV             | RF                | US        |    441531 | NS      | $441531.03    | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| LIGAND PHARMACEUTICALS INCORPORATED                                        | LIGAND PHARMACEUTICALS                            | CUSIP: 53220K504<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |     53395 | NS      | $6069943.60   | 1.10%             |  |  |  | No            |                  1 | On Loan: —       |
| ELANCO ANIMAL HEALTH INCORPORATED                                          | ELANCO ANIMAL HEALTH INC                          | CUSIP: 28414H103<br>LEI: 549300SHPNDCE059M934 | Long             | EC               | CORP              | US        |   1374428 | NS      | $19626831.84  | 3.57%             |  |  |  | No            |                  1 | On Loan: —       |
| BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | BLACKROCK CASH FUNDS INSTITUTIONAL FUND SL AGENCY | CUSIP: 066922519<br>LEI: N/A                  | Long             | STIV             | RF                | US        |  31978693 | NS      | $31991484.20  | 5.81%             |  |  |  | No            |                  1 | On Loan: No      |
| WAVE Life Sciences Ltd                                                     | WAVE LIFE SCIENCES LTD                            | CUSIP: Y95308105<br>LEI: 54930070006GPKFYZ813 | Long             | EC               | CORP              | SG        |    328188 | NS      | $2133222.00   | 0.39%             |  |  |  | No            |                  1 | On Loan: —       |
| BRISTOL-MYERS SQUIBB CO                                                    | BRISTOL MYERS SQUIBB CO                           | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |    505212 | NS      | $23386263.48  | 4.25%             |  |  |  | No            |                  1 | On Loan: No      |
| PERRIGO COMPANY PUBLIC LIMITED COMPANY                                     | PERRIGO CO PLC                                    | CUSIP: G97822103<br>LEI: 549300IFOQS6R1QLY196 | Long             | EC               | CORP              | IE        |    380455 | NS      | $10165757.60  | 1.85%             |  |  |  | No            |                  1 | On Loan: No      |
| ELI LILLY AND COMPANY                                                      | ELI LILLY CO                                      | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |    156697 | NS      | $122150012.41 | 22.19%            |  |  |  | No            |                  1 | On Loan: No      |
| JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY                                | JAZZ PHARMACEUTICALS PLC                          | CUSIP: G50871105<br>LEI: 635400GAUMJCLEZRRV50 | Long             | EC               | CORP              | IE        |    170564 | NS      | $18100251.68  | 3.29%             |  |  |  | No            |                  1 | On Loan: —       |
| ZOETIS INC.                                                                | ZOETIS INC                                        | CUSIP: 98978V103<br>LEI: 549300HD9Q1LOC9KLJ48 | Long             | EC               | CORP              | US        |    152356 | NS      | $23759918.20  | 4.32%             |  |  |  | No            |                  1 | On Loan: No      |
| JOHNSON & JOHNSON                                                          | JOHNSON JOHNSON                                   | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |    816097 | NS      | $124658816.75 | 22.65%            |  |  |  | No            |                  1 | On Loan: No      |
| OCULAR THERAPEUTIX, INC.                                                   | OCULAR THERAPEUTIX INC                            | CUSIP: 67576A100<br>LEI: 529900ABAWFXOHSIHG03 | Long             | EC               | CORP              | US        |    357087 | NS      | $3313767.36   | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| INNOVIVA, INC.                                                             | INNOVIVA INC                                      | CUSIP: 45781M101<br>LEI: 549300ACOX4QTBES6535 | Long             | EC               | CORP              | US        |    152853 | NS      | $3070816.77   | 0.56%             |  |  |  | No            |                  1 | On Loan: —       |
| Edgewise Therapeutics Inc                                                  | EDGEWISE THERAPEUTICS INC                         | CUSIP: 28036F105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    192041 | NS      | $2517657.51   | 0.46%             |  |  |  | No            |                  1 | On Loan: —       |
| Evolus Inc                                                                 | EVOLUS INC                                        | CUSIP: 30052C107<br>LEI: 549300VYQRYBQOT8V419 | Long             | EC               | CORP              | US        |    139403 | NS      | $1283901.63   | 0.23%             |  |  |  | No            |                  1 | On Loan: —       |
| AXSOME THERAPEUTICS, INC.                                                  | AXSOME THERAPEUTICS INC                           | CUSIP: 05464T104<br>LEI: 549300EXGR0XLRJEIB95 | Long             | EC               | CORP              | US        |    114455 | NS      | $11947957.45  | 2.17%             |  |  |  | No            |                  1 | On Loan: No      |
| Tarsus Pharmaceuticals Inc                                                 | TARSUS PHARMACEUTICALS INC                        | CUSIP: 87650L103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    105805 | NS      | $4286160.55   | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Arvinas Inc                                                                | ARVINAS INC                                       | CUSIP: 04335A105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    188168 | NS      | $1384916.48   | 0.25%             |  |  |  | No            |                  1 | On Loan: —       |
| HARMONY BIOSCIENCES HOLDINGS, INC.                                         | HARMONY BIOSCIENCES HOLDINGS INC                  | CUSIP: 413197104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    106473 | NS      | $3364546.80   | 0.61%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvation Bio Inc                                                           | NUVATION BIO INC                                  | CUSIP: 67080N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    714683 | NS      | $1393631.85   | 0.25%             |  |  |  | No            |                  1 | On Loan: —       |
| ORGANON & CO.                                                              | ORGANON CO                                        | CUSIP: 68622V106<br>LEI: 549300AMCKY57OK2CO56 | Long             | EC               | CORP              | US        |    719404 | NS      | $6963830.72   | 1.27%             |  |  |  | No            |                  1 | On Loan: No      |
| PFIZER INC.                                                                | PFIZER INC                                        | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |   1035191 | NS      | $25093029.84  | 4.56%             |  |  |  | No            |                  1 | On Loan: No      |
| HARROW, INC.                                                               | HARROW INC                                        | CUSIP: 415858109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     87311 | NS      | $2666477.94   | 0.48%             |  |  |  | No            |                  1 | On Loan: —       |
| CORCEPT THERAPEUTICS INCORPORATED                                          | CORCEPT THERAPEUTICS INC                          | CUSIP: 218352102<br>LEI: 529900EO9LUTFMZ7FF90 | Long             | EC               | CORP              | US        |    261189 | NS      | $19171272.60  | 3.48%             |  |  |  | No            |                  1 | On Loan: —       |
| AMPHASTAR PHARMACEUTICALS INC                                              | AMPHASTAR PHARMACEUTICALS INC                     | CUSIP: 03209R103<br>LEI: 54930055TH0ZLSAQMJ38 | Long             | EC               | CORP              | US        |    101686 | NS      | $2334710.56   | 0.42%             |  |  |  | No            |                  1 | On Loan: No      |
| MERCK & CO., INC.                                                          | MERCK CO INC                                      | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |    315506 | NS      | $24975454.96  | 4.54%             |  |  |  | No            |                  1 | On Loan: No      |
| AMNEAL PHARMACEUTICALS, INC.                                               | AMNEAL PHARMACEUTICALS INC                        | CUSIP: 03168L105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    416287 | NS      | $3367761.83   | 0.61%             |  |  |  | No            |                  1 | On Loan: No      |
| ANI PHARMACEUTICALS, INC.                                                  | ANI PHARMACEUTICALS INC                           | CUSIP: 00182C103<br>LEI: 5493000T6CXTND40YH31 | Long             | EC               | CORP              | US        |     47078 | NS      | $3071839.50   | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| XAV HEALTH CARE SEP25                                                      | XAV HEALTH CARE SEP25                             | CUSIP: N/A<br>LEI: N/A                        | N/A              | DE               |  | US        |         4 | NC      | $4249.85      | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| SUPERNUS PHARMACEUTICALS, INC.                                             | SUPERNUS PHARMACEUTICALS INC                      | CUSIP: 868459108<br>LEI: 549300GRM36VBKISYJ58 | Long             | EC               | CORP              | US        |    154947 | NS      | $4883929.44   | 0.89%             |  |  |  | No            |                  1 | On Loan: —       |
| PRESTIGE CONSUMER HEALTHCARE INC.                                          | PRESTIGE CONSUMER HEALTH                          | CUSIP: 74112D101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    136752 | NS      | $10919647.20  | 1.98%             |  |  |  | No            |                  1 | On Loan: No      |
| Enliven Therapeutics Inc                                                   | ENLIVEN THERAPEUTICS INC                          | CUSIP: 29337E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    108281 | NS      | $2172116.86   | 0.39%             |  |  |  | No            |                  1 | On Loan: —       |
| Liquidia Corp                                                              | LIQUIDIA CORP                                     | CUSIP: 53635D202<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    132275 | NS      | $1648146.50   | 0.30%             |  |  |  | No            |                  1 | On Loan: —       |
| THERAVANCE BIOPHARMA, INC.                                                 | THERAVANCE BIOPHARMA INC                          | CUSIP: G8807B106<br>LEI: 5493007VTSXP4Z6MIW52 | Long             | EC               | CORP              | KY        |     98371 | NS      | $1085032.13   | 0.20%             |  |  |  | No            |                  1 | On Loan: No      |
| PACIRA BIOSCIENCES, INC.                                                   | PACIRA BIOSCIENCES INC                            | CUSIP: 695127100<br>LEI: 549300P56LERYBDHCF69 | Long             | EC               | CORP              | US        |    128123 | NS      | $3062139.70   | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| ROYALTY PHARMA PLC                                                         | ROYALTY PHARMA PLC                                | CUSIP: G7709Q104<br>LEI: 549300FGFN7VOK8BZR03 | Long             | EC               | CORP              | GB        |    744243 | NS      | $26815075.29  | 4.87%             |  |  |  | No            |                  1 | On Loan: No      |
| VIATRIS INC.                                                               | VIATRIS INC                                       | CUSIP: 92556V106<br>LEI: 254900ZZTSW7NL773X71 | Long             | EC               | CORP              | US        |   2821990 | NS      | $25200370.70  | 4.58%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-07-30

**Name of Applicant:** iShares Trust

**Signature:** Chuck Pulsfort

**Name of Signer:** Chuck Pulsfort

**Title:** Assistant Treasurer